APTEVO THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Nov 2024)
What this means for you
Registered since 21 Nov 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86768978
- Registration number
- 5341248
- Mark type
- Stylized text
- Filed
- 25 Sept 2015
- Published for opposition
- 23 Feb 2016
- Registered
- 21 Nov 2017
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, immune system diseases and disorders, auto immune system diseases, and blood disorders, none of the foregoing related to oncology
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields, none of the foregoing related to oncology
Owner
- APTEVO RESEARCH AND DEVELOPMENT LLC, Seattle, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, SEATTLE, WA, US
- Emergent Product Development Seattle, LLC, Seattle, WA, US
- Emergent Product Development Seattle, LLC, Seattle, WA, US
Prosecution history
- 06 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Nov 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 May 2024 — TEAS SECTION 8 & 15 RECEIVED
- 21 Nov 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Nov 2017 — REGISTERED-PRINCIPAL REGISTER
- 19 Oct 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Oct 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Oct 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Oct 2017 — USE AMENDMENT FILED
- 06 Oct 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Oct 2017 — TEAS STATEMENT OF USE RECEIVED
- 02 Oct 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Sept 2017 — CORRECTED NOA E-MAILED
- 25 Sept 2017 — POST PUBLICATION AMENDMENT - ENTERED